REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 11th, 2016 • Transgenomic Inc • Laboratory analytical instruments
Contract Type FiledJanuary 11th, 2016 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of January 8, 2016, by and among Transgenomic, Inc., a Delaware corporation (the “Company”), and the several signatories hereto (each, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 11th, 2016 • Transgenomic Inc • Laboratory analytical instruments • New York
Contract Type FiledJanuary 11th, 2016 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January 6, 2016 by and among Transgenomic, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
TRANSGENOMIC, INC. WARRANT TO PURCHASE COMMON STOCKSecurities Agreement • January 11th, 2016 • Transgenomic Inc • Laboratory analytical instruments • New York
Contract Type FiledJanuary 11th, 2016 Company Industry JurisdictionTransgenomic, Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, ____________, the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant to Purchase Common Stock (including any Warrant(s) to Purchase Common Stock issued in exchange, transfer or replacement hereof, this “Warrant”), at any time or times beginning on the date that is six months from the Issuance Date (the “Initial Exercise Date”) but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), One Hundred Seven Thousand Five Hundred Twenty-Seven (107,527) (subject to adjustment as provided herein) fully paid and non-assessable shares of Common Stock (as defined below) (the “Warrant Shares”). Except as otherwise